Study Finds Oral Azacitidine as AML Maintenance Treatment Prolongs Survival
February 3rd 2021Patients with AML that has gone into remission following initial chemotherapy were found to remain in remission longer and have improved OS if they took a pill form of azacitidine as a maintenance treatment.
Read More
Efficacy and Safety of FOLFIRI for Previously Treated Advanced Pancreatic Cancer
January 29th 2021The treatment of 5-fluorouracil with levofolinate and irinotecan was found to be well-tolerated and effective as a second-line treatment for patients with gemcitabine-refractory advanced pancreatic cancer.
Read More
Walgreens Provides an Update on COVID-19 Vaccination Administration Across the Country
January 28th 2021In a progress update on COVID-19 vaccine administration and testing in Walgreens pharmacies, speakers discussed the rollout and implementation of the COVID-19 vaccination process in LTC facilities.
Read More
Data Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC
January 27th 2021Data from a phase 1b/2 study investigating onvansertib as a treatment of KRAS-mutated mCRC demonstrated that 42% of patients achieved a PR and 67% demonstrated a durable response ranging from 6.1 months to 13.7 months.
Read More
NCPA Urges Biden Administration to Consider Independent Pharmacies as Part of COVID-19 Strategy
January 26th 2021Following the release of the Biden administration’s COVID-19 response strategy, NCPA issued its support and urged the government to also consider engaging independent pharmacies in its implementation.
Read More
FDA Approves Rilpivirine, Cabotegravir as the First Long-Acting Regimen for HIV Treatment
January 23rd 2021The FDA has approved cabenuva, which consists of rilpivirine and cabotegravir, for treating HIV-1 infection in adults. This therapy is the first once-monthly, long-acting injectable to be approved for the treatment of HIV.
Read More
Triggering a Tumor Antiviral Immune Response in Patients With Triple-Negative Breast Cancer
January 22nd 2021During a study investigating therapeutics that target how RNA splicing activates antiviral immune pathways in triple-negative breast cancers, researchers observed that endogenous RNA in tumor cells that had been mis-spliced is able to mimic an RNA virus.
Read More
APhA: Biden $1.9 Trillion COVID-19 Plan is Strong Start to Recovery From Pandemic
January 15th 2021In a statement by the APhA, Scott J. Knoer, executive vice president and CEO of APhA, noted the association’s support for this first step by the Biden administration on the road to recovery from the pandemic.
Read More
Potential Source of Chronic Inflammation in Patients With Obesity May Lead to Treatment
January 6th 2021Chronic, low-level inflammation is one of the main causes of the diseases associated with obesity. For this reason, researchers investigated which cell type was responsible for triggering inflammation in fat tissue.
Read More